| # | Drug | Count |
|---|---|---|
| 0 | TENOFOVIR DISOPROXIL FUMARATE | 110 |
| 1 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 71 |
| 2 | LAMIVUDINE | 60 |
| 3 | LAMIVUDINE ORAL | 56 |
| 4 | FUROSEMIDE | 41 |
| 5 | RITONAVIR | 41 |
| 6 | EMTRICITABINE | 38 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 34 |
| 8 | RITONAVIR 100 MG | 34 |
| 9 | TACROLIMUS | 33 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 25 | 0.0197 |
| 1 | KAOLIN | 1 | 0.0182 |
| 2 | DEMECLOCYCLINE | 3 | 0.0132 |
| 3 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 71 | 0.0082 |
| 4 | ATAZANAVIR AND COBICISTAT | 2 | 0.0082 |
| 5 | BRINCIDOFOVIR | 1 | 0.0072 |
| 6 | SACROSIDASE | 1 | 0.0055 |
| 7 | RALTEGRAVIR | 22 | 0.0042 |
| 8 | DARUNAVIR 600 MG | 19 | 0.0031 |
| 9 | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | 1 | 0.0030 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 64 | 0.0013 |
| 2 | Protease Inhibitor [EPC] | 55 | 0.0012 |
| 3 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 132 | 0.0012 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 27 | 0.0011 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 64 | 0.0011 |
| 7 | Actinomycin [EPC] | 2 | 0.0009 |
| 8 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 14 | 0.0007 |